D.E. Shaw & Co
SRDX

D.E. Shaw & Co’s Surmodics SRDX Stock Holding History

D.E. Shaw & Co’s Portfolio SRDX Stock Details SRDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-14,400
Closed -$681K – 3901
2018
Q4 		$681K Buy
14,400
+200
+1% +$12K ﹤0.01% 2911
2018
Q3 		$1.06M Buy
+14,200
New +$978K ﹤0.01% 2668

Other funds holding SRDX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

D.E. Shaw & Co's SRDX Position: Q4 2025 in Review

D.E. Shaw & Co sold out of Surmodics (SRDX) in Q4 2025, closing a stake of 74,422 shares — an estimated $2.22M sold.

D.E. Shaw & Co first reported a position in SRDX in Q3 2013 and held it in 45 quarters. The position peaked at $4.99M in Q4 2024. 1 fund tracked by Wall St. Rank holds SRDX as of Q4 2025.

  • D.E. Shaw & Co reported no remaining Surmodics position as of Q4 2025 after selling out during the quarter.
  • D.E. Shaw & Co sold 74,422 Surmodics shares in Q4 2025, an estimated $2.22M.
  • D.E. Shaw & Co first reported a position in Surmodics in Q3 2013 and held it in 45 quarters.
  • D.E. Shaw & Co's Surmodics position peaked at $4.99M in Q4 2024.
  • 1 fund tracked by Wall St. Rank held Surmodics as of Q4 2025.

Based on D.E. Shaw & Co's 13F filing for Q4 2025, filed 17 Feb 2026.